# The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)

> **NCT01766518** · PHASE4 · UNKNOWN · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 120 (estimated)

## Conditions studied

- Evidence of Liver Transplantation

## Interventions

- **DRUG:** Mycophenolate mofetil

## Key facts

- **NCT ID:** NCT01766518
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2014-04
- **Final completion:** 2014-05
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2013-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01766518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01766518, "The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01766518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*